Result Summary for APV10020
| Protocol ID: | APV10020 |
| Clinical Study ID: | APV10020 |
| Official Title: | A Phase I, Open Label, Two Period, Single-Sequence, Drug-Drug Interaction Study Comparing Steady-State Plasma Ethinyl Estradiol and Norethisterone Pharmacokinetics following Administration of Brevinor for 21 Days with and without Fosamprenavir 700 mg Twice Daily (BID) and Ritonavir 100 mg BID fo ... |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | Telzer,Telzir,Lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
